Summit Therapeutics plc Aktie
-
Deine Einschätzung
Was spricht für und gegen Summit Therapeutics plc in den nächsten Jahren?
Pro
Kontra
Rendite von Summit Therapeutics plc im Vergleich
Wertpapier | Ver.(%) | 1W | 1M | 1J | YTD | 3J | 5J |
---|---|---|---|---|---|---|---|
Summit Therapeutics plc | - | - | - | - | - | - | - |
Proteome Sciences | 10,34 % | 3,23 % | -48,39 % | -52,94 % | -44,83 % | -55,56 % | -50,77 % |
Oxford BioMedica PLC | 3,73 % | 13,01 % | 7,75 % | 55,83 % | 36,27 % | 74,62 % | -23,69 % |
Sareum Holdings plc | - | -4,44 % | 17,27 % | -11,03 % | -14,57 % | -90,08 % | - |
Kommentare
News

1 Monster Stock in the Making to Buy and Hold
Even in hindsight, it would have been difficult to predict Summit Therapeutics' (NASDAQ: SMMT) exceptional rise over the past three years. The company's shares have skyrocketed by more than 1,500%

Summit Financial Wealth Advisors Loads Up on Lockheed Martin (LMT) With 12K Shares
Summit Financial Wealth Advisors, LLC established a new position in Lockheed Martin(NYSE:LMT), acquiring 12,393 shares valued at approximately $5.74 million as of the second quarter ended June 30

Why BlackSky Stock Popped Today
Shares of Earth-imaging satellites company BlackSky Technology (NYSE: BKSY) soared 13.5% through 3 p.m. ET Thursday -- probably because of a couple of tweets posted on X announcing BlackSky's plans